The Quercus Trust

The Quercus Trust is a private investment vehicle founded by David Gelbaum that focuses on transformative technologies in clean energy and the life sciences. In the biotechnology sector, the trust is known for providing significant early-stage and growth capital to companies specializing in regenerative medicine, longevity, and oncology. Notable investments include positions in Lineage Cell Therapeutics, AgeX Therapeutics, and Oisín Biotechnologies. The trust operates with a long-term perspective, often acting as a cornerstone investor for high-risk, high-reward scientific ventures. It does not maintain an internal drug development pipeline, instead functioning as a strategic financial partner to innovative biotech firms.